Broker notes, analysis and comments
Mortgage Advice Bureau (Holdings) Plc (LON:MAB1) interim results to 20 June 2017 reveal profitable growth: * 14% yoy rise in average adviser numbers to 974 (1H16: 851); * 15% yoy..
Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investment initiatives have..
Gateley (Holdings) Plc (LON:GTLY) is a broad-based UK legal services firm. It floated on AIM in mid-2015. It is a leader in the UK mid market, having grown strongly over..
After enjoying a flood of investment in July, the level of new funds finding their way into AIM’s Oil & Gas Exploration & Production sector slowed to a trickle in..
Safestyle UK Plc (LON:SFE) has released interim results for the six months ended 30 June. Revenue of £82.5m is +1.4% YoY (HY16 restated: £81.4m) however an increase in costs driven..
According to the US Securities and Exchange Commission, “Cashflow statements report a company’s inflows and outflows of cash”. This is such a simple and obvious statement. Unfortunately, the failure of..
Action Hotels plc (LON:AHCG), the leading owner, developer and asset manager of branded three and four-star hotels in the Middle East and Australia, announced today its unaudited results for the..
This month the MSCI Emerging Markets Index (MXEF) rose 1% to 1100 (up 8.8% since 30 June 2017) and Sterling strengthened 5% to £1 = US$1.35 (12% above its January..
What’s new Yesterday Xafinity Plc (LON:XAF) and Markets Authority, “CMA”, launched a market investigation into investment consultancy and fiduciary management services. Yesterday, Xafinity’s Head of Pension Investment commented: “[Xafinity] fully..
Purplebricks Group plc (LON: PURP), the hybrid estate agent, announced today that it is formally launching its business in the US later today. In line with the region by region..
Oxford Biomedica plc (LON:OXB) is a specialist advanced therapy viral-vector biopharmaceutical company. It offers vector manufacturing and development services, whilst retaining proprietary drug candidates. OXB will also receive royalties on..
Diurnal Group Plc (LON:DNL) is a clinical stage specialty pharmaceutical company focused on diseases of the endocrine system. Its two lead candidates are targeted at rare diseases with unmet medical..
1pm Plc (LON:OPM) offers a unique exposure to the attractive UK, non-bank, SME financing market. We believe it can deliver superior growth from: (i) focussed business units delivering high service..
PPHE Hotel Group Ltd (LON:PPH) reported interim results which were higher than our expectations and we are modestly increasing our forecasts for this year and next. Current profitability is constrained..
ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are..
Tatton Asset Management Plc (LON:TAM) In the fast-moving world of UK financial services, firms of Independent Financial Advisers (“IFAs”) need support. In 2007, Tatton Asset Management (the “Group”) launched Paradigm..
SigmaRoc plc, (LON:SRC) the AIM listed buy-and-build construction materials group, announced today its unaudited interim results for the six months ended 30 June 2017. Highlights: 6 months to 30 June..
Epwin Group Plc (LON: EPWN), the low maintenance building products manufacturer, supplying businesses in the Repair, Maintenance and Improvement (“RMI”), new build and social housing sectors, announced today its half..
Harvey Nash Group Plc (LON:HVN) are the topic of conversation with Zeus Capital’s head of Research Mike Allen. Mike provides some company background, shares his thoughts on the acquisition of..
Diversified Gas & Oil Plc (LON:DCOG) when it floated on AIM in February 2017, offered it’s investors a unique proposition among its UK-listed oil and gas exploration and production peers...
